 |
|
Unimpaired Verbal Memory and Oculomotor Control in Asymptomatic Adults With the Genetic Marker for Huntington's Disease
Johannes C. Rothlind, PhD;
Jason Brandt, PhD;
David Zee, MD;
Ann Marie Codori, PhD;
Susan Folstein, MD
Arch Neurol. 1993;50(8):799-802.
Abstract
| |
• Objective.
—To determine whether asymptomatic individuals at very high genetic risk for Huntington's disease (HD) have demonstrable cognitive or oculomotor abnormalities.
Design.
—A case-control study was employed. Presence of the chromosome-4 DNA marker linked to the HD phenotype was the criterion for HD risk.
Setting.
—The Baltimore Huntington's Disease Project Presymptomatic Testing Program at The Johns Hopkins University School of Medicine, Baltimore, Md.
Participants.
—Seventy-six asymptomatic adults at risk for HD, voluntarily enrolled for genetic testing, and determined by clinical examination to be free of major psychiatric disorder or evidence of HD. Twenty were determined to be at 95% risk for HD; 56 were at 15% risk.
Measures.
—The Hopkins Verbal Learning Test was used to assess verbal learning and memory. Oculomotor functioning was assessed using Novel-Stimulus, Mirror-Stimulus, and Predictive-Saccade paradigms. Outcome measures included number of correctly recalled words, recognition accuracy, and response bias, as well as saccade latency and number of errors on the Mirror-Stimulus Test.
Results.
—With one exception, all participants performed within the normal range on the Hopkins Verbal Learning Test. In a blind follow-up examination of the individual who performed aberrantly on the Hopkins Verbal Learning Test, she exhibited neurologic and psychiatric changes sufficient for a clinical diagnosis of HD. There were no group differences on the tests of oculomotor functioning.
Conclusions.
—Young, asymptomatic adults at very high genetic risk for HD are unimpaired in tests of verbal learning and memory and oculomotor functioning.
Author Affiliations
From the Departments of Psychiatry and Behavioral Sciences (Drs Rothlind, Brandt, Codori, and Folstein) and Neurology (Dr Zee), The Johns Hopkins University School of Medicine, Baltimore, Md.
Footnotes
Accepted for publication January 19, 1993.
Reprint requests to the Division of Medical Psychology, Meyer 218, The Johns Hopkins University School of Medicine, 600 N Wolfe St, Baltimore, MD 21205 (Dr Brandt).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Decreased frontal choline and neuropsychological performance in preclinical Huntington disease
Gomez-Anson et al.
Neurology 2007;68:906-910.
ABSTRACT
| FULL TEXT
Specific Psychiatric Manifestations Among Preclinical Huntington Disease Mutation Carriers
Marshall et al.
Arch Neurol 2007;64:116-121.
ABSTRACT
| FULL TEXT
Saccades in presymptomatic and early stages of Huntington disease
Blekher et al.
Neurology 2006;67:394-399.
ABSTRACT
| FULL TEXT
Cognitive and Motor Functioning in Gene Carriers for Huntington's Disease: A Baseline Study
Witjes-Ane et al.
J. Neuropsychiatry Clin. Neurosi. 2003;15:7-16.
ABSTRACT
| FULL TEXT
Behavioural complaints in participants who underwent predictive testing for Huntington's disease
Witjes-Ane et al.
J. Med. Genet. 2002;39:857-862.
FULL TEXT
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers
Hahn-Barma et al.
J. Neurol. Neurosurg. Psychiatry 1998;64:172-177.
ABSTRACT
| FULL TEXT
Cognitive Manifestations of Huntington Disease in Relation to Genetic Structure and Clinical Onset
Jason et al.
Arch Neurol 1997;54:1081-1088.
ABSTRACT
Motor Changes in Presymptomatic Huntington Disease Gene Carriers
Siemers et al.
Arch Neurol 1996;53:487-492.
ABSTRACT
|
